GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
L81.0
Postinflammatory hyperpigmentation
ICD10CM code
Medical Policies and Guidelines for Postinflammatory hyperpigmentation
Related policies from health plans
ANTHEM-BLUECROSS-CA
Serum iron Testing
ANTHEM-BLUECROSS-CT
CG-LAB-21 Serum Iron Testing
Similar Codes
ICD10CM codes
L81.0
- Postinflammatory hyperpigmentation
L81.4
- Other melanin hyperpigmentation
L81.7
- Pigmented purpuric dermatosis
L81
- Other disorders of pigmentation
L81.9
- Disorder of pigmentation, unspecified
L81.8
- Other specified disorders of pigmentation
Q82.1
- Xeroderma pigmentosum
H18.05
- Posterior corneal pigmentations
L80
- Vitiligo
L53.3
- Other chronic figurate erythema
HCPCS codes
E0202
- Phototherapy (bilirubin) light with photometer
G8908
- Patient documented to have received a burn prior to discharge
Q4186
- Epifix, per square centimeter
S0800
- Laser in situ keratomileusis (lasik)
G8749
- Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or
G0429
- Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a resu
G9929
- Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardi
D7410
- EXCISION OF BENIGN LESION UP TO 1.25 CM
D7411
- EXCISION OF BENIGN LESION GREATER THAN 1.25 CM
V2632
- Posterior chamber intraocular lens
CPT4 codes
11922
- Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, i
96904
- Whole body integumentary photography, for monitoring of high risk patients with dysplastic nevus syn
11921
- Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, i
11920
- Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, i
17107
- Destruction of cutaneous vascular proliferative lesions (eg, laser technique); 10.0 to 50.0 sq cm
68135
- Destruction of lesion, conjunctiva
96920
- Laser treatment for inflammatory skin disease (psoriasis); total area less than 250 sq cm
96922
- Laser treatment for inflammatory skin disease (psoriasis); over 500 sq cm
96921
- Laser treatment for inflammatory skin disease (psoriasis); 250 sq cm to 500 sq cm
17106
- Destruction of cutaneous vascular proliferative lesions (eg, laser technique); less than 10 sq cm